Whitefort Capital Management, LP

In its 13F for Q2 2025 (holdings as of June 30, 2025, filed November 12, 2025), Whitefort Capital Management, LP reported 14 stock positions worth $239.0 million. Its top holding was Joyy Inc.-ADR (JOYY) at 19.5% of the portfolio, followed by Roivant Sciences (ROIV, 18.3%) and Arbutus Biopharma (ABUS, 17.3%). Compared with Q1 2025, it opened 4 new positions, sold out of 1, added to 7 and reduced 1. The biggest buy was a new position in USA Today (TDAY) and the biggest sale Global Ship Lease Class A (GSL, shares −4%).

Most Recent 13F
Q2 2026
Location
NEW YORK, NY
CIK
0001884931
Portfolio Value
$239.0M (Q2 2025)
SEC Filing
0001013594-25-001353 ↗ filed Nov 12, 2025

Holdings Value

0$100.0M$200.0M$300.0M$400.0M Q1 2024: $153.2M Q1 2024 Q2 2024: $143.4M Q2 2024 Q3 2024: $201.5M Q3 2024 Q4 2024: $191.5M Q4 2024 Q1 2025: $185.2M Q1 2025 Q2 2025: $239.0M $239.0M Q2 2025 Q3 2025: $287.4M Q3 2025 Q4 2025: $317.7M Q4 2025 Q1 2026: $316.6M Q1 2026 Q2 2026: $391.6M Q2 2026

Holdings 14 stocks · $239.0M
JOYY Joyy Inc.-ADR 19.49% 914,943 $46.6M Add +20.5%
ROIV Roivant Sciences Ltd. 18.30% 3,882,000 $43.8M Add +13.8%
ABUS Arbutus Biopharma Corp. 17.25% 13,343,228 $41.2M Add +0.3%
GNW Genworth Financial Inc. 10.49% 3,221,960 $25.1M Add +7.9%
OABI Omniab Inc. 7.45% 10,240,146 $17.8M Add +161.6%
LQDA Liquidia Corp. 6.94% 1,331,602 $16.6M Add +26.8%
CDZI Cadiz Inc. 4.99% 3,986,822 $11.9M Add +7.2%
TDAY USA Today Co. Inc. filed as GANNETT CO INC 4.00% 2,671,921 $9.6M New
GSL Global Ship Lease Inc. Class A 3.90% 353,857 $9.3M Reduce -4.3%
SGRY Surgery Partners Inc. 3.45% 371,000 $8.2M New
VATE Innovate Corp. 1.60% 743,000 $3.8M No change
KG Kestrel Group 1.13% 102,206 $2.7M New
OPK Opko Health Inc. 0.98% 1,774,200 $2.3M New
TRINITY BIOTECH INVT LTD 0.02% 81,902 $53K No change

Options reported separately and not counted above: GLD calls ($8.2M).

Other holdings (3): bonds, preferreds, convertibles and warrants · $19.5M (not counted above)
SecurityClassShares / PrincipalValueChange
OPKO HEALTH INC (OPK 3.75 01/15/29) NOTE 3.750% 1/1 · principal 9,350,000$12.9MNo change
INNOVATE CORP (VATE 7.5 08/01/26 *) NOTE 7.500% 8/0 · principal 12,218,000$6.3MNo change
NNAVW Nextnav Inc. *W EXP 99/99/999 47,264$300KNo change

Total filed on the 13F, all lines: $258.5M.

Portfolio Sells Q1 2025 → Q2 2025
GSL Global Ship Lease Inc. Class A Reduce -4.3% 3.90% −0.67
MHLD Maiden Holdings Ltd. Sold out 0.00% −0.62

Portfolio Buys Q1 2025 → Q2 2025
TDAY USA Today Co. Inc. New 4.00% +4.00
SGRY Surgery Partners Inc. New 3.45% +3.45
OABI Omniab Inc. Add +161.6% 7.45% +2.38
JOYY Joyy Inc.-ADR Add +20.5% 19.49% +2.27
KG Kestrel Group New 1.13% +1.13
OPK Opko Health Inc. New 0.98% +0.98
ROIV Roivant Sciences Ltd. Add +13.8% 18.30% −0.28
CDZI Cadiz Inc. Add +7.2% 4.99% −0.90
GNW Genworth Financial Inc. Add +7.9% 10.49% −0.95
LQDA Liquidia Corp. Add +26.8% 6.94% −1.42
ABUS Arbutus Biopharma Corp. Add +0.3% 17.25% −7.83

Options Activity Q1 2025 → Q2 2025
GLD SPDR Gold Shares call New 27,000 $8.2M

Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.

Notes & Other Activity Q1 2025 → Q2 2025
SABRE GLBL INC (SABHLD 4 04/15/25) NOTE 4.000% 4/1 · principal Sold out 5,000,000 $5.0Mbefore exit

Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 18$391.6MABUS, ROIV, JOYY, BALY, GNW
Q1 2026 17$316.6MABUS, ROIV, JOYY, SOC, GNW
Q4 2025 15$317.7MABUS, ROIV, BALY, OABI, JOYY
Q3 2025 14$287.4MABUS, ROIV, GNW, JOYY, OABI
Q2 2025Amended 14$239.0MJOYY, ROIV, ABUS, GNW, OABI
Q1 2025 11$185.2MABUS, ROIV, JOYY, GNW, LQDA
Q4 2024 13$191.5MABUS, ROIV, LQDA, GNW, CDZI
Q3 2024 13$201.5MABUS, EDR, ROIV, JOYY, GNW
Q2 2024 16$143.4MABUS, ROIV, NN, GNW, GSL
Q1 2024 13$153.2MGSL, ABUS, ROIV, LSXMK, GNW